RT @Labome: Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single‐cell transcript…
Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single‐cell transcriptomics. https://t.co/phRQFldwaZ https://t.co/hifgy29Lpp
RT @LogosBiosystems: Almost every patient with multiple #myeloma, a form of blood #cancer, becomes unresponsive to drugs. 💊 Now, a single-c…
RT @LogosBiosystems: Almost every patient with multiple #myeloma, a form of blood #cancer, becomes unresponsive to drugs. 💊 Now, a single-c…
RT @LogosBiosystems: Almost every patient with multiple #myeloma, a form of blood #cancer, becomes unresponsive to drugs. 💊 Now, a single-c…
Almost every patient with multiple #myeloma, a form of blood #cancer, becomes unresponsive to drugs. 💊 Now, a single-cell #transcriptomics study using the LUNA #CellCounter has identified genetic variations that could help us to target #drugresistance. htt
RT @NatureComms: #scRNAseq analysis of relapsed/refractory #MultipleMyeloma by @SMTirier, @KarstenRippe and colleagues reveals prognostic 1…
RT @NatureComms: #scRNAseq analysis of relapsed/refractory #MultipleMyeloma by @SMTirier, @KarstenRippe and colleagues reveals prognostic 1…
RT @KarstenRippe: Our single cell analysis of relapsed/refractory multiple #myeloma is out https://t.co/ENDOtM00vm @NatureComms. Great team…
RT @NatureComms: #scRNAseq analysis of relapsed/refractory #MultipleMyeloma by @SMTirier, @KarstenRippe and colleagues reveals prognostic 1…
RT @NatureComms: #scRNAseq analysis of relapsed/refractory #MultipleMyeloma by @SMTirier, @KarstenRippe and colleagues reveals prognostic 1…
RT @NatureComms: #scRNAseq analysis of relapsed/refractory #MultipleMyeloma by @SMTirier, @KarstenRippe and colleagues reveals prognostic 1…
RT @NatureComms: #scRNAseq analysis of relapsed/refractory #MultipleMyeloma by @SMTirier, @KarstenRippe and colleagues reveals prognostic 1…
RT @NatureComms: #scRNAseq analysis of relapsed/refractory #MultipleMyeloma by @SMTirier, @KarstenRippe and colleagues reveals prognostic 1…
RT @NatureComms: #scRNAseq analysis of relapsed/refractory #MultipleMyeloma by @SMTirier, @KarstenRippe and colleagues reveals prognostic 1…
RT @NatureComms: #scRNAseq analysis of relapsed/refractory #MultipleMyeloma by @SMTirier, @KarstenRippe and colleagues reveals prognostic 1…
RT @NatureComms: #scRNAseq analysis of relapsed/refractory #MultipleMyeloma by @SMTirier, @KarstenRippe and colleagues reveals prognostic 1…
#scRNAseq analysis of relapsed/refractory #MultipleMyeloma by @SMTirier, @KarstenRippe and colleagues reveals prognostic 1q gain and the impact of therapy and tumour progression on the #microenvironment #CancerResearch @NatResCancer https://t.co/QfZovMn
RT @sccHeidelberg: Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single-cell tra…
Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single-cell transcriptomics https://t.co/nYhtqBbTFM
Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single-cell transcriptomics https://t.co/OMnTvBROof https://t.co/k2NZQ8tmku
RT @KarstenRippe: Our single cell analysis of relapsed/refractory multiple #myeloma is out https://t.co/ENDOtM00vm @NatureComms. Great team…
New article: Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single-cell transcriptomics https://t.co/HzGAjI7J91 #MMSM #MultipleMyeloma #hematology https://t.co/CiAdlgNEsL
RT @SMTirier: (1/17) Our single cell transcriptomics study of refractory multiple myeloma is out in @NatureComms (From my time in the lab o…
RT @SMTirier: (1/17) Our single cell transcriptomics study of refractory multiple myeloma is out in @NatureComms (From my time in the lab o…
RT @SMTirier: (1/17) Our single cell transcriptomics study of refractory multiple myeloma is out in @NatureComms (From my time in the lab o…
RT @SMTirier: (1/17) Our single cell transcriptomics study of refractory multiple myeloma is out in @NatureComms (From my time in the lab o…
RT @KarstenRippe: Our single cell analysis of relapsed/refractory multiple #myeloma is out https://t.co/ENDOtM00vm @NatureComms. Great team…
RT @SMTirier: (1/17) Our single cell transcriptomics study of refractory multiple myeloma is out in @NatureComms (From my time in the lab o…
RT @SMTirier: (1/17) Our single cell transcriptomics study of refractory multiple myeloma is out in @NatureComms (From my time in the lab o…
RT @KarstenRippe: Our single cell analysis of relapsed/refractory multiple #myeloma is out https://t.co/ENDOtM00vm @NatureComms. Great team…
RT @SMTirier: (1/17) Our single cell transcriptomics study of refractory multiple myeloma is out in @NatureComms (From my time in the lab o…
I was miles out of my depth trying to read this piece; that said, there's lots here about changes to 1q & how they happen, and some thoughts about possible ways to avoid imid resistance.
RT @SMTirier: (1/17) Our single cell transcriptomics study of refractory multiple myeloma is out in @NatureComms (From my time in the lab o…
RT @SMTirier: (1/17) Our single cell transcriptomics study of refractory multiple myeloma is out in @NatureComms (From my time in the lab o…
RT @SMTirier: (1/17) Our single cell transcriptomics study of refractory multiple myeloma is out in @NatureComms (From my time in the lab o…
RT @SMTirier: (1/17) Our single cell transcriptomics study of refractory multiple myeloma is out in @NatureComms (From my time in the lab o…
RT @SMTirier: (1/17) Our single cell transcriptomics study of refractory multiple myeloma is out in @NatureComms (From my time in the lab o…
RT @SMTirier: (1/17) Our single cell transcriptomics study of refractory multiple myeloma is out in @NatureComms (From my time in the lab o…
RT @SMTirier: (1/17) Our single cell transcriptomics study of refractory multiple myeloma is out in @NatureComms (From my time in the lab o…
RT @SMTirier: (1/17) Our single cell transcriptomics study of refractory multiple myeloma is out in @NatureComms (From my time in the lab o…
RT @KarstenRippe: Our single cell analysis of relapsed/refractory multiple #myeloma is out https://t.co/ENDOtM00vm @NatureComms. Great team…
RT @KarstenRippe: Our single cell analysis of relapsed/refractory multiple #myeloma is out https://t.co/ENDOtM00vm @NatureComms. Great team…
RT @SMTirier: (1/17) Our single cell transcriptomics study of refractory multiple myeloma is out in @NatureComms (From my time in the lab o…
RT @KarstenRippe: Our single cell analysis of relapsed/refractory multiple #myeloma is out https://t.co/ENDOtM00vm @NatureComms. Great team…
RT @KarstenRippe: Our single cell analysis of relapsed/refractory multiple #myeloma is out https://t.co/ENDOtM00vm @NatureComms. Great team…
RT @KarstenRippe: Our single cell analysis of relapsed/refractory multiple #myeloma is out https://t.co/ENDOtM00vm @NatureComms. Great team…
RT @KarstenRippe: Our single cell analysis of relapsed/refractory multiple #myeloma is out https://t.co/ENDOtM00vm @NatureComms. Great team…
RT @KarstenRippe: Our single cell analysis of relapsed/refractory multiple #myeloma is out https://t.co/ENDOtM00vm @NatureComms. Great team…
RT @SMTirier: (1/17) Our single cell transcriptomics study of refractory multiple myeloma is out in @NatureComms (From my time in the lab o…
RT @SMTirier: (1/17) Our single cell transcriptomics study of refractory multiple myeloma is out in @NatureComms (From my time in the lab o…
RT @KarstenRippe: Our single cell analysis of relapsed/refractory multiple #myeloma is out https://t.co/ENDOtM00vm @NatureComms. Great team…
RT @KarstenRippe: Our single cell analysis of relapsed/refractory multiple #myeloma is out https://t.co/ENDOtM00vm @NatureComms. Great team…
RT @SMTirier: (1/17) Our single cell transcriptomics study of refractory multiple myeloma is out in @NatureComms (From my time in the lab o…
RT @KarstenRippe: Our single cell analysis of relapsed/refractory multiple #myeloma is out https://t.co/ENDOtM00vm @NatureComms. Great team…
Check this out @GastonGenomics @DalPathology - Dan please forward to Manal.
RT @KarstenRippe: Our single cell analysis of relapsed/refractory multiple #myeloma is out https://t.co/ENDOtM00vm @NatureComms. Great team…
RT @SMTirier: (1/17) Our single cell transcriptomics study of refractory multiple myeloma is out in @NatureComms (From my time in the lab o…
Our single cell analysis of relapsed/refractory multiple #myeloma is out https://t.co/ENDOtM00vm @NatureComms. Great team effort driven by @SMTirier with Marc Raab group and collaborators @DKFZ @med5_ukhd @NCT_HD. Open sc-seq omics postdoc position: https:
RT @SMTirier: (1/17) Our single cell transcriptomics study of refractory multiple myeloma is out in @NatureComms (From my time in the lab o…
RT @SMTirier: (1/17) Our single cell transcriptomics study of refractory multiple myeloma is out in @NatureComms (From my time in the lab o…
RT @SMTirier: (1/17) Our single cell transcriptomics study of refractory multiple myeloma is out in @NatureComms (From my time in the lab o…
(1/17) Our single cell transcriptomics study of refractory multiple myeloma is out in @NatureComms (From my time in the lab of @KarstenRippe)! Huge THANK YOU to all people involved! Some highlights in the thread below. https://t.co/DDPIJz7frr